Emerging mechanisms and targeted therapy of ferroptosis in cancer
Open accessThe DOI matches its Crossref record; 292 of the 292 references it cites were found in a registry or an index.
Abstract
Ferroptosis is an iron- and lipid reactive oxygen species (ROS)-dependent form of programmed cell death that is distinct from other forms of regulatory cell death at the morphological, biological, and genetic levels. Emerging evidence suggests critical roles for ferroptosis in cell metabolism, the redox status, and various diseases, such as cancers, nervous system diseases, and ischemia-reperfusion injury, with ferroptosis-related proteins. Ferroptosis is inhibited in diverse cancer types and functions as a dynamic tumor suppressor in cancer development, indicating that the regulation of ferroptosis can be utilized as an interventional target for tumor treatment. Small molecules and nanomaterials that reprogram cancer cells to undergo ferroptosis are considered effective drugs for cancer therapy. Here, we systematically summarize the molecular basis of ferroptosis, the suppressive effect of ferroptosis on tumors, the effect of ferroptosis on cellular metabolism and the tumor microenvironment (TME), and ferroptosis-inducing agents for tumor therapeutics. An understanding of the latest progress in ferroptosis could provide references for proposing new potential targets for the treatment of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–292 of 292
Qi, W., Li, Z., Xia, L., Dai, J., Zhang, Q., Wu, C., & Xu, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-52837-8 · Cited by 226
Histone Modifications: Insights into Their Influence on Gene Expression
Stillman, B. (2018) · Cell · doi:10.1016/j.cell.2018.08.032 · Cited by 225
Sui, S., Zhang, J., Xu, S., Wang, Q., Wang, P., & Pang, D. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1564-7 · Cited by 221
ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway
Chen, J., Ding, C., Chen, Y., Hu, W., Yu, C., Peng, C., Feng, X., Cheng, Q., Wu, W., Lu, Y., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2020.12.019 · Cited by 219
Epigenetic regulation of ferroptosis by H2B monoubiquitination and p53
Wang, Y., Yang, L., Zhang, X., Cui, W., Liu, Y., Sun, Q., He, Q., Zhao, S., Zhang, G., Wang, Y., et al. (2019) · EMBO reports · doi:10.15252/embr.201847563 · Cited by 214
Role of ferritin alterations in human breast cancer cells
Shpyleva, S. I., Tryndyak, V. P., Kovalchuk, O., Starlard-Davenport, A., Chekhun, V. F., Beland, F. A., & Pogribny, I. P. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0849-4 · Cited by 206
Cao, J. Y., Poddar, A., Magtanong, L., Lumb, J. H., Mileur, T. R., Reid, M. A., Dovey, C. M., Wang, J., Locasale, J. W., Stone, E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.043 · Cited by 206
HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRASQ61L cells.
Ye, F., Chai, W., Xie, M., Yang, M., Yan, Y., Cao, L., & Yang, L. (2019) · PubMed · Cited by 202
FANCD2 protects against bone marrow injury from ferroptosis
Song, X., Xie, Y., Kang, R., Hou, W., Sun, X., Epperly, M. W., Greenberger, J. S., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.068 · Cited by 201
Editorial: Impact of Lipid Peroxidation on the Physiology and Pathophysiology of Cell Membranes
Catalá, A., & Díaz, M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00423 · Cited by 200
Daher, B., Parks, S. K., Durivault, J., Cormerais, Y., Baidarjad, H., Tambutte, E., Pouysségur, J., & Vučetić, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3855 · Cited by 200
Statins as Anticancer Agents in the Era of Precision Medicine
Longo, J., van Leeuwen, J. E., Elbaz, M., Branchard, E., & Penn, L. Z. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1967 · Cited by 196
The anti-inflammatory mechanism of sulfasalazine is related to adenosine release at inflamed sites
Gadangi, P., Longaker, M., Naime, D., Levin, R. I., Recht, P. A., Montesinos, M. C., Buckley, M. T., Carlin, G., & Cronstein, B. N. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.5.1937 · Cited by 196
Savaskan, N. E., Heckel, A., Hahnen, E., Engelhorn, T., Doerfler, A., Ganslandt, O., Nimsky, C., Buchfelder, M., & Eyüpoglu, I. Y. (2008) · Nature Medicine · doi:10.1038/nm1772 · Cited by 192
Hasegawa, M., Takahashi, H., Rajabi, H., Alam, M., Suzuki, Y., Yin, L., Tagde, A., Maeda, T., Hiraki, M., Sukhatme, V. P., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7598 · Cited by 191
NEET Proteins: A New Link Between Iron Metabolism, Reactive Oxygen Species, and Cancer
Mittler, R., Darash-Yahana, M., Sohn, Y. S., Bai, F., Song, L., Cabantchik, I. Z., Jennings, P. A., Onuchic, J. N., & Nechushtai, R. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7502 · Cited by 186
Sleire, L., Skeie, B. S., Netland, I. A., Førde, H. E., Dodoo, E., Selheim, F., Leiss, L., Heggdal, J. I., Pedersen, P.-H., Wang, J., et al. (2015) · Oncogene · doi:10.1038/onc.2015.60 · Cited by 175
miR‐9 regulates ferroptosis by targeting glutamic‐oxaloacetic transaminase GOT1 in melanoma
Zhang, K., Wu, L., Zhang, P., Luo, M., Du, J., Gao, T., O'Connell, D., Wang, G., Wang, H., & Yang, Y. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22878 · Cited by 171
Self-citationXiao, F.-J., Zhang, D., Wu, Y., Jia, Q.-H., Zhang, L., Li, Y.-X., Yang, Y.-F., Wang, H., Wu, C.-T., & Wang, L.-S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.147 · Cited by 169
Self-citationEmerging Role of Ferroptosis in Acute Kidney Injury
Hu, Z., Zhang, H., Yang, S.-K., Wu, X., He, D., Cao, K., & Zhang, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8010614 · Cited by 168
The deubiquitinase OTUD1 enhances iron transport and potentiates host antitumor immunity
Song, J., Liu, T., Yin, Y., Zhao, W., Lin, Z., Yin, Y., Lü, D., & You, F. (2021) · EMBO Reports · doi:10.15252/embr.202051162 · Cited by 167
Cell growth dilutes the cell cycle inhibitor Rb to trigger cell division
Zatulovskiy, E., Zhang, S., Berenson, D. F., Topacio, B. R., & Skotheim, J. M. (2020) · Science · doi:10.1126/science.aaz6213 · Cited by 166
Li, Z., Jiang, L., Chew, S. H., Hirayama, T., Sekido, Y., & Toyokuni, S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101297 · Cited by 163
miR-212-5p attenuates ferroptotic neuronal death after traumatic brain injury by targeting Ptgs2
Xiao, X., Jiang, Y., Liang, W., Wang, Y., Cao, S., Yan, H., Gao, L., & Zhang, L. (2019) · Molecular Brain · doi:10.1186/s13041-019-0501-0 · Cited by 163
Lipid peroxidation: control of cell proliferation, cell differentiation and cell death
Barrera, G., Pizzimenti, S., & Dianzani, M. U. (2008) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.09.012 · Cited by 160
Nγ-Aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site
Esslinger, C. S., Cybulski, K. A., & Rhoderick, J. F. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.11.028 · Cited by 158
Speer, R. E., Karuppagounder, S. S., Basso, M., Sleiman, S. F., Kumar, A., Brand, D., Smirnova, N., Gazaryan, I., Khim, S. J., & Ratan, R. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.01.026 · Cited by 155
Magtanong, L., & Dixon, S. J. (2018) · Developmental Neuroscience · doi:10.1159/000496922 · Cited by 155
Torti, S. V., & Torti, F. M. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100860 · Cited by 153
Lipid homeostasis and regulated cell death
Agmon, E., & Stockwell, B. R. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.06.002 · Cited by 153
Nagpal, A., Redvers, R. P., Ling, X., Ayton, S., Fuentes, M., Tavancheh, E., Diala, I., Lalani, A., Loi, S., David, S., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1177-1 · Cited by 151
Redox-dependent gating of VDAC by mitoNEET
Lipper, C. H., Stofleth, J. T., Bai, F., Sohn, Y., Roy, S., Mittler, R., Nechushtai, R., Onuchic, J. N., & Jennings, P. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908271116 · Cited by 151
Hypoxia Post-translationally Activates Iron-regulatory Protein 2
Hanson, E. S., Foot, L. M., & Leibold, E. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5047 · Cited by 150
Effect of antioxidants on cultured human diploid fibroblasts exposed to cystine-free medium
Bannai, S., Tsukeda, H., & Okumura, H. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90623-4 · Cited by 143
NF-κB, Nrf2, and HO-1 Interplay in Redox-Regulated VCAM-1 Expression
Banning, A., & Brigelius-Flohé, R. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.889 · Cited by 142
ROS Promotes Cancer Cell Survival through Calcium Signaling
Reczek, C. R., & Chandel, N. S. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.010 · Cited by 142
Saturated Fatty Acids, MUFAs and PUFAs Regulate Ferroptosis
Das, U. N. (2019) · Cell chemical biology · doi:10.1016/j.chembiol.2019.03.001 · Cited by 142
Iron and magnetic: new research direction of the ferroptosis-based cancer therapy.
Wang, S., Luo, J., Zhang, Z., Dong, D., Shen, Y., Fang, Y., Hu, L., Liu, M., Dai, C., Peng, S., et al. (2018) · Europe PMC (PubMed Central) · Cited by 141
Houessinon, A., François, C., Sauzay, C., Louandre, C., Mongelard, G., Godin, C., Bodeau, S., Takahashi, S., Saidak, Z., Gutierrez, L., et al. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0526-2 · Cited by 137
Guan, J., Lo, M., Dockery, P., Mahon, S., Karp, C. M., Buckley, A. R., Lam, S., Gout, P. W., & Wang, Y.-Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0894-4 · Cited by 134
Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
Guo, W., Zhao, Y., Zhang, Z., Tan, N., Zhao, F., Ge, C., Liang, L., Jia, D., Chen, T., Yao, M., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.07.024 · Cited by 134
Yamaguchi, H., Hsu, J. L., Chen, C.-T., Wang, Y.-N., Hsu, M.-C., Chang, S.-S., Du, Y., Ko, H.-W., Herbst, R., & Hung, M.-C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2621 · Cited by 129
The transport of glutamine into mammalian cells
McGivan, J. (2007) · Frontiers in Bioscience · doi:10.2741/2109 · Cited by 128
Ramnarine, V. R., Kobelev, M., Gibb, E. A., Nouri, M., Lin, D., Wang, Y. Z., Buttyan, R., Davicioni, E., Zoubeidi, A., & Collins, C. C. (2019) · European Urology · doi:10.1016/j.eururo.2019.07.040 · Cited by 127
MicroRNA-214-3p enhances erastin-induced ferroptosis by targeting ATF4 in hepatoma cells
Bai, T., Liang, R., Zhu, R., Wang, W., Zhou, L., & Sun, Y. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29496 · Cited by 125
The Antioxidant Role of Non-mitochondrial CoQ10: Mystery Solved!
Santoro, M. M. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.12.007 · Cited by 122
Lo, M., Ling, V., Low, C., Wang, Y. Z., & Gout, P. W. (2010) · Current Oncology · doi:10.3747/co.v17i3.485 · Cited by 120
Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation
Li, T., Mao, C., Wang, X., Shi, Y., & Tao, Y. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01733-5 · Cited by 120
Self-citationComporti, M., Saccocci, C., & Dianzani, U. (1965) · PubMed · Cited by 117
Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers
Gomaa, A. R., Peng, D., Chen, Z., Soutto, M., Abouelezz, K., Corvalán, A. H., & El-Rifai, W. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-53174-6 · Cited by 116
T HE G ENETICS OF F ATTY A CID M ETABOLISM IN S ACCHAROMYCES C EREVISIAE
Trotter, P. J. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.97 · Cited by 114
Inhibition of Ferroptosis Attenuates Acute Kidney Injury in Rats with Severe Acute Pancreatitis
Ma, D., Li, C., Jiang, P., Jiang, Y., Wang, J., & Zhang, D. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06225-2 · Cited by 113
Moosmann, B., & Behl, C. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2004.08.003 · Cited by 111
Huang, C., Yang, M., Deng, J., Li, P., Su, W., & Jiang, R. (2018) · Oncology Reports · doi:10.3892/or.2018.6585 · Cited by 110
Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11
Wang, Y., Zhao, Y., Wang, H., Zhang, C., Wang, M., Yang, Y., Xu, X., & Hu, Z. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.12823 · Cited by 110
Self-citationCong, L., Dong, X., Wang, Y., Deng, Y., Li, B., & Dai, R. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.039 · Cited by 106
Deng, G., Li, Y., Ma, S., Gao, Z., Zeng, T., Chen, L., Ye, H., Yang, M., Shi, H., Yao, X., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.12.026 · Cited by 101
Iron regulatory proteins control a mucosal block to intestinal iron absorption
Galy, B., Ferring-Appel, D., Becker, C., Gretz, N., Gröne, H.-J., Schümann, K., & Hentze, M. W. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.02.026 · Cited by 98
Martens, S., Jeong, M., Tonnus, W., Feldmann, F., Hofmans, S., Goossens, V., Takahashi, N., Bräsen, J. H., Lee, E., der Veken, P. V., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.298 · Cited by 96
STYK1/NOK correlates with ferroptosis in non-small cell lung carcinoma
Lai, Y., Zhang, Z., Li, J., Li, W., Huang, Z., Zhang, C., Li, X., & Zhao, J. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.032 · Cited by 92
Antiferroptotic activity of non-oxidative dopamine
Wang, D., Peng, Y., Xie, Y., Zhou, B., Sun, X., Kang, R., & Tang, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.099 · Cited by 91
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research
Ooi, A. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.10.016 · Cited by 90
The Biosynthesis of Cystine in Human Cell Cultures
Eagle, H., Piez, K. A., & Oyama, V. I. (1961) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64190-0 · Cited by 89
Blocking tumor cell eicosanoid synthesis by GPx4 impedes tumor growth and malignancy
Heirman, I., Ginneberge, D., Brigelius‐Flohé, R., Hendrickx, N., Agostinis, P., Brouckaert, P., Rottiers, P., & Grooten, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.033 · Cited by 87
An important role of the hepcidin–ferroportin signaling in affecting tumor growth and metastasis
Guo, W., Zhang, S., Chen, Y., Zhang, D., Yuan, L., Cong, H., & Liu, S. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv063 · Cited by 84
Self-citationVillalpando-Rodriguez, G. E., Blankstein, A. R., Konzelman, C., & Gibson, S. B. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9561281 · Cited by 84
Schneider, M., Wortmann, M., Mandal, P. K., Arpornchayanon, W., Jannasch, K., Alves, F., Strieth, S., Conrad, M., & Beck, H. (2010) · Neoplasia · doi:10.1593/neo.91782 · Cited by 80
Hippo pathway effectors YAP/TAZ as novel determinants of ferroptosis
Yang, W., & Chi, J. (2019) · Molecular & Cellular Oncology · doi:10.1080/23723556.2019.1699375 · Cited by 77
Wenk, J., Schüller, J., Hinrichs, C., Syrovets, T., Azoitei, N., Podda, M., Wlaschek, M., Brenneisen, P., Schneider, L.-A., Sabiwalsky, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408893200 · Cited by 76
Selenium-Encoded Isotopic Signature Targeted Profiling
Gao, J., Yang, F., Che, J., Han, Y., Wang, Y., Chen, N., Bak, D. W., Lai, S., Xie, X., Weerapana, E., et al. (2018) · ACS Central Science · doi:10.1021/acscentsci.8b00112 · Cited by 75
Low tumor glutathione level as a sensitivity marker for glutamate‑cysteine ligase inhibitors
Nishizawa, S., Araki, H., Ishikawa, Y., Kitazawa, S., Hata, A., Soga, T., & Hara, T. (2018) · Oncology Letters · doi:10.3892/ol.2018.8447 · Cited by 74
Ferroptosis and kidney diseases
Tang, S., & Xiao, X. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02335-7 · Cited by 70
Cell–cell contacts protect against t-BuOOH-induced cellular damage and ferroptosis in vitro
Wenz, C., Faust, D., Linz, B., Turmann, C., Nikolova, T., & Dietrich, C. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02413-w · Cited by 62
Liu, X., Zhang, X., Peng, Z., Li, C., Wang, Z., Wang, C., Deng, Z., Wu, B., Cui, Y., Wang, Z., et al. (2020) · Advanced Science · doi:10.1002/advs.201902040 · Cited by 60
Xia, H., Lee, K. W., Chen, J., Kong, S. N., Sekar, K., Deivasigamani, A., Seshachalam, V. P., Goh, B. K. P., Ooi, L. L., & Hui, K. M. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.58 · Cited by 59
Yu, H., Han, Z., Xu, Z., An, C., Xu, L., & Hua, X. (2019) · Oncology Letters · doi:10.3892/ol.2019.10191 · Cited by 50
Douglas, G., Hale, A. B., Patel, J., Chuaiphichai, S., Al Haj Zen, A., Rashbrook, V. S., Trelfa, L., Crabtree, M. J., McNeill, E., & Channon, K. M. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy078 · Cited by 49
Ferroptosis: Yet Another Way to Die
Kazan, K., & Kalaipandian, S. (2019) · Trends in Plant Science · doi:10.1016/j.tplants.2019.03.005 · Cited by 49
Glucose and glutamine in poliovirus production by HeLa cells
Darnell, J. E., Jr., & Eagle, H. (1958) · Virology · doi:10.1016/0042-6822(58)90102-8 · Cited by 47
Rohr‐Udilova, N., Bauer, E., Timelthaler, G., Eferl, R., Stolze, K., Pinter, M., Seif, M., Hayden, H., Reiberger, T., Schulte‐Hermann, R., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24300 · Cited by 46
Activation of proinflammatory signaling by 4-hydroxynonenal-Src adducts in aged kidneys
Jang, E. J., Kim, D. H., Lee, B., Lee, E. K., Chung, K. W., Moon, K. M., Kim, M. J., An, H. J., Jeong, J. W., Kim, Y. R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10854 · Cited by 44
Li, X.-M., Salomon, R. G., Qin, J., & Hazen, S. L. (2007) · Biochemistry · doi:10.1021/bi700163y · Cited by 43
Li, H., Yang, H., Li, P., Li, M., Yao, Q., Li, M., Zhang, Y., Wang, J., & Zheng, N. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.126368 · Cited by 41
DUBbing Ferroptosis in Cancer Cells
Gan, B. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0487 · Cited by 40
Werth, E. G., Rajbhandari, P., Stockwell, B. R., & Brown, L. M. (2020) · PROTEOMICS · doi:10.1002/pmic.202000006 · Cited by 36
Kim, R. D., Tan, E. S., Wang, E., Mahipal, A., Chen, D., Cao, B., Masawi, F., Machado, C., Yu, J. B., & Kim, D. W. (2020) · The Oncologist · doi:10.1634/theoncologist.2020-0759 · Cited by 33
Ferroptosis‐Suppressor‐Protein 1: A Potential Neuroprotective Target for Combating Ferroptosis
Chen, L., & Xie, J. (2020) · Movement Disorders · doi:10.1002/mds.27990 · Cited by 29
Prominin-2 Suppresses Ferroptosis Sensitivity
Belavgeni, A., Bornstein, S. R., & Linkermann, A. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.11.004 · Cited by 25
Jiang, S., Guo, S., Li, H., Ni, Y., Ma, W., & Zhao, R. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00819 · Cited by 20
Ferroptosis-like death in plant cells
Conlon, M., & Dixon, S. J. (2017) · Molecular & Cellular Oncology · doi:10.1080/23723556.2017.1302906 · Cited by 19
Enhancement of melphalan activity by buthionine sulfoximine and electroporation in melanoma cells
Ongaro, A., Pellati, A., Mattei, M. D., de Terlizzi, F., Rossi, C. R., & Campana, L. G. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000192 · Cited by 17
Microenvironmental cues in cancer stemness
Flanagan, D. J., Hodder, M. C., & Sansom, O. J. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0210-4 · Cited by 10
Cited by
Ferroptosis in cancer and cancer immunotherapy
Zhao, L., Zhou, X., Xie, F., Zhang, L., Yan, H., Huang, J., Zhang, C., Zhou, F., Chen, J., & Zhang, L. (2022) · Cancer Communications · doi:10.1002/cac2.12250 · Cited by 684
Self-citationWu, S., Wu, X., Wang, Q., Chen, Z., Li, L., Chen, H., & Qi, H. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156130 · Cited by 27
Metadata
- Authors
- Wang, H., Cheng, Y., Mao, C., Liu, S., Xiao, D., Huang, J., & Tao, Y.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 29
- Issue
- 7
- Pages
- 2185-2208
- ISSN
- 1525-0016 (ISSN-L)
- OpenAlex
- W3147852499
- Cited by
- 312
- References
- 292
- FWCI
- 30.78
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.